2017 – Genetic disruption of oncogenic Kras sensitizes lung cancer cells to Fas receptor-mediated apoptosis
Mou, H. (2017).
Proceedings of the National Academy of Sciences, 114(14), 3648–3653.
Read full publication
OV‘s second drug candidate in the clinic – First Multiple Myeloma patient in study with APO010, an Immuno-Oncology drug